Historical Intravenous Data Made CBD Bioavailability Estimates Approximate

The reported absolute bioavailability of a hemp cosmetic product was estimated using intravenous data from earlier research. It was not measured against an intravenous arm in the same participants.

The calculation crossed study boundaries

The paper reports estimated oral and topical CBD bioavailability of 10.18% and 0.69%. Its calculation combined route-specific exposure with previously published intravenous pharmacokinetic data. The current crossover compared oral and topical administration; it did not include an intravenous CBD treatment.

The reference data introduce uncertainty

Absolute bioavailability calculations depend on the reference exposure as well as the tested dose and route. The authors identify differences in populations, formulation, sampling duration and analytical methods as possible sources of variability when historical intravenous data are used. The numerical precision of the percentages does not remove those differences.

Observed exposure supports a narrower comparison

The trial’s measured concentration profiles supported greater systemic CBD exposure after oral administration than after application of this cosmetic oil. That within-study observation is different from establishing an exact fraction entering the circulation. The authors characterize the absolute estimates as approximate and hypothesis-generating. They should not be used as precise conversion factors between a person’s topical and oral doses, nor extended to other products without relevant data. Retaining the distinction between directly observed exposure and a historical-reference calculation makes the finding more useful rather than discarding it.

Related analysis: interpreting the study’s urine and plasma findings.

Research cited

Jain and colleagues. Results of an Exploratory Crossover Pharmacokinetic Study Evaluating a Natural Hemp Extract-Based Cosmetic Product: Comparison of Topical and Oral Routes of Administration. Pharmaceuticals (2026). DOI: 10.3390/ph19020231.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Cannabis Law’s Enactment Date Was Not the Same Exposure Measure as Retail Access

The driving review identifies a timing problem in policy research: passing a cannabis law and making products available for purchase can occur at different times. A before-and-after comparison needs an exposure definition that matches its question. The review described a gap between milestones Pearlson and colleagues note that retail access…

Spread the love

Read Article: A Cannabis Law’s Enactment Date Was Not the Same Exposure Measure as Retail Access

A Proposed Cannabis-Impairment Fingerprint Was Not a Validated Diagnostic Battery

The driving review suggested that a combination of behavioral deficits might form a useful cannabis-impairment pattern. It presented that as a research possibility, not a completed diagnostic validation. The proposal aimed to combine information The reviewers considered whether several deficits unlikely to co-occur by chance could support a characteristic pattern….

Spread the love

Read Article: A Proposed Cannabis-Impairment Fingerprint Was Not a Validated Diagnostic Battery

A Laboratory Cannabis Screen Needed Evidence That It Worked in Roadside Conditions

A cognitive screen that performs well in a quiet laboratory is not automatically validated for a roadside setting. The driving review identifies practical environmental demands as part of the testing problem. The proposed use environment was demanding The review describes testing at night with limited light and passing-traffic noise. A…

Spread the love

Read Article: A Laboratory Cannabis Screen Needed Evidence That It Worked in Roadside Conditions

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us